Amazon targets Medplus and two of our investing themes

Amazon targets Medplus and two of our investing themes

As we saw this past Prime Day 2018, Amazon is targeting international expansion of its Prime services. It’s also doing the same with its acquisition of online pharmacy as PillPack it looks to disrupt the pharmacy market, an event that we here at Tematica are anxiously awaiting. As Amazon builds on PillPack that acquisition should pave the way for Amazon feeling the benefits of our Aging of the Population tailwind to a much greater degree. Now with Amazon reportedly looking to acquire MedPlus, an Indian pharmacy chain, it looks to leverage both of these strategies — targeting international markets and disrupting the pharmacy market — which would serve to expand its footing inside our New Middle Class investing theme as well as our Aging of the Population one.

 

Amazon is reportedly engaged in deal talks about acquiring MedPlus, the Indian pharmacy chain.According to Reuters, citing FactorDaily, the Indian news website, sources said the talks are in the early stages. MedPlus Health Services operates more than 1,500 pharmacies in India, and also operates lab testing centers and has a surgical equipment distribution unit. “We do not comment on what we may do or may not do in the future,” an Amazon spokesperson told Reuters.In late June, Amazon announced it had inked a deal to acquire PillPack, the pharmacy focused on people in the U.S. who take multiple daily prescriptions.

Source: Amazon In Talks To Acquire India’s MedPlus | PYMNTS.com

About the Author

Chris Versace, Chief Investment Officer
I'm the Chief Investment Officer of Tematica Research and editor of Tematica Investing newsletter. All of that capitalizes on my near 20 years in the investment industry, nearly all of it breaking down industries and recommending stocks. In that time, I've been ranked an All Star Analyst by Zacks Investment Research and my efforts in analyzing industries, companies and equities have been recognized by both Institutional Investor and Thomson Reuters’ StarMine Monitor. In my travels, I've covered cyclicals, tech and more, which gives me a different vantage point, one that uses not only an ecosystem or food chain perspective, but one that also examines demographics, economics, psychographics and more when formulating my investment views. The question I most often get is "Are you related to…."

Comments are closed.